GlassScriptPhysician profile
Paul D Saadi
NPI 1841203379
$55,487.32
in general payments reported to CMS, 2019-2025
32 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,021 · 2020: $2,337 · 2021: $24K · 2022: $13K · 2023: $1,846 · 2024: $849 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,550 · Food and Beverage: $3,105 · Travel and Lodging: $2,455 · Gift: $23.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,550.00 |
| Food and Beverage | $3,104.56 |
| Travel and Lodging | $2,455.29 |
| Gift | $23.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $38,901.45 | 2019-2025 | Gamma, Stryker Nav3i, Variax |
| Restor3d, INC. | $8,260.64 | 2024-2025 | |
| Shoulder Innovations, INC. | $3,001.82 | 2023-2025 | Inset System |
| Zimmer Biomet Holdings, INC. | $1,247.57 | 2019-2024 | Rosa |
| Pylant Medical | $932.79 | 2020-2025 | |
| Arthrex, INC. | $581.40 | 2020 | |
| Si-Bone, INC. | $515.89 | 2019-2023 | |
| Ossdsign USA Incorporated | $371.64 | 2025 | Ossdsign Catalyst |
| Conformis, INC. | $339.87 | 2020-2021 | |
| Orthofix Medical, INC. | $192.62 | 2022-2024 | Cervical-Stim, Spinal-Stim |
| Medtronic USA, INC. | $162.48 | 2019 | |
| Smith+Nephew, INC. | $161.83 | 2023-2025 | Bone Anchors With Arthroscopic Delivery System, Na, Coblation |
| Providence Medical Technology, INC. | $158.92 | 2023-2024 | |
| Medacta USA, INC. | $95.94 | 2023 | Reverse Shoulder |
| Davol INC. | $91.37 | 2021-2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $58.00 | 2022-2023 | Stratafix, Ethicon, Vistaseal |
| Vericel Corporation | $45.69 | 2019-2023 | Maci |
| Linvatec Corporation | $40.97 | 2025 | Biobrace 23mm |
| Innovation Technologies INC | $40.49 | 2022 | |
| Abbott Laboratories | $40.23 | 2020-2025 | Eterna |
| Bioventus LLC | $29.85 | 2020 | |
| Centinel Spine, LLC | $28.62 | 2025 | Prodisc C Vivo |
| Radius Health, INC. | $25.05 | 2022 | |
| Integra Lifesciences Corporation | $23.19 | 2022 | |
| Carbofix Orthopedics INC | $22.16 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $21.11 | 2021 | |
| Heron Therapeutics, INC. | $20.82 | 2021 | |
| Pfizer INC. | $17.45 | 2021 | |
| Baudax Bio INC. | $16.82 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $16.13 | 2020 | |
| Djo, LLC | $12.77 | 2021 | |
| Bsn Medical INC | $11.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$170,594.71 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Saadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.